Vertiv stock (VRT) ends week higher after a wild swing — what investors watch next
25 January 2026
2 mins read

Vertiv stock (VRT) ends week higher after a wild swing — what investors watch next

New York, Jan 25, 2026, 04:55 EST — Market closed

Shares of Vertiv Holdings Co (VRT.N) ended Friday’s session 0.8% higher, closing at $182.49. The stock capped off a volatile week for data-center infrastructure players, with traders now eyeing Monday’s Fed announcements and major tech earnings reports.

The timing is crucial as markets zero in once more on whether AI investments are translating into profits or just swelling costs. “Earnings are the driver,” said Franklin Templeton senior market strategist Chris Galipeau. Apple, Microsoft, Meta, and Tesla are all set to report earnings in the next few days. 1

Vertiv has a clear connection here. The company sells power and cooling equipment that supports AI workloads, meaning cloud capital expenditures can rapidly translate into its orders and service needs.

Friday’s trading was choppy. Shares dropped to a low of $175.73, then climbed as high as $183.72 before closing, with roughly 3.5 million changing hands, according to Nasdaq data. 2

Vertiv added a fresh angle for investors late last week. The company rolled out Vertiv Next Predict, an AI-driven managed service designed to detect issues in data-center gear before uptime takes a hit — relying on real-time operational data rather than scheduled inspections. 3

“Vertiv Next Predict helps data centers unlock uptime,” said Ryan Jarvis, vice president of Vertiv’s global services business unit, in the announcement. The company said the service employs anomaly detection and predictive algorithms to identify risks in power, cooling, and IT systems. 4

Broader markets offered little support for the calm. On Friday, the Dow slipped while the Nasdaq inched up, dragged down by Intel’s drop after a weak forecast, despite gains from Nvidia, Reuters reported. Janus Henderson portfolio manager Julian McManus described it as a “show-me” moment for AI-related stocks. 5

The Federal Reserve’s policy meeting is set for Jan. 27-28, with a rate decision expected on Wednesday followed by a press conference, according to the central bank’s calendar. Bets on interest rates have been shifting among high-growth stocks, a group that often includes Vertiv. 6

Vertiv is set to announce its fourth-quarter and full-year 2025 earnings before the market opens on Feb. 11. The company will hold a conference call at 11 a.m. ET that day. 7

During the call, investors usually drill down on orders and backlog, as well as price and supply trends. They also want to know how much of the AI expansion is shifting from one-off equipment sales to steady, repeatable service revenue.

The immediate threat is clear: a sour note from Washington or a cautious outlook from Big Tech could knock anything linked to AI development, Vertiv among them. Markets have been reactive to tariff news and rapid swings in risk appetite. One money manager summed it up as waking up uncertain whether it’s “Christmas morning or Friday the 13th.” 8

Coming soon: Monday’s reopening, the Fed’s decision midweek, and Vertiv’s report on Feb. 11 — the next clear signal on whether the data-center trade is truly picking up speed or just growing more expensive.

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
New York, Feb 7, 2026, 09:39 EST — Market closed. Apple Inc (AAPL.O) shares ended Friday up 0.8% at $278.12 after swinging between $276.92 and $280.90, before dipping 0.3% in after-hours trading. U.S. markets are shut on Saturday, but the stock goes into Monday with a familiar question back on the tape: will Apple raise iPhone prices, or eat higher costs. 1 The immediate pressure point is memory. A tightening supply of DRAM — the memory chips that help phones run power-hungry apps smoothly — is pushing up component costs just as investors are re-pricing the economics of the broader
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Vertical Aerospace stock price (EVTL) slips as Valo New York push meets dilution worries
Previous Story

Vertical Aerospace stock price (EVTL) slips as Valo New York push meets dilution worries

Bloom Energy stock price heads into Monday after Friday dip as data centers talk more onsite power
Next Story

Bloom Energy stock price heads into Monday after Friday dip as data centers talk more onsite power

Go toTop